Core Viewpoint - The announcement details a change in the shareholding structure of Nuo Cheng Jian Hua Pharmaceutical Co., Ltd, indicating a reduction in the stake held by major shareholders, specifically King Limited and Success Growth Limited, from 8.08% to 7.54% [1][2]. Group 1: Shareholding Changes - The total shareholding percentage of King Limited and Success Growth Limited decreased from 8.08% to 7.54% [1][2]. - The number of shares held by these shareholders reduced from 14,239,205.4 thousand shares to 13,290.0430 thousand shares [1][2]. - The change in shareholding does not trigger mandatory tender offer obligations and does not violate any prior commitments [1]. Group 2: Impact on Company Governance - The primary shareholder has not changed, indicating that the governance structure and ongoing operations of the company will not be significantly affected [2]. - The company will continue to fulfill its information disclosure obligations regarding any future changes in shareholding [2].
诺诚健华: 诺诚健华医药有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告